| Prev Close | 3.42 |
| Open | 3.36 |
| Day Low/High | 3.30 / 3.41 |
| 52 Wk Low/High | 2.76 / 6.57 |
| Volume | 158.01K |
| Avg Volume | 106.00K |
| Exchange | NASDAQ |
| Shares Outstanding | 28.73M |
| Market Cap | 98.54M |
| EPS | 0.10 |
| P/E Ratio | 26.38 |
| Div & Yield | N.A. (N.A) |
Latest News
EDAP Reports Superior Outcomes Of Focal Ablatherm-HIFU Compared To Robotic Radical Prostatectomy
Similar Cancer Control at 5 Years, Significantly Less Incidence of Incontinence and Erectile Dysfunction
EDAP Announces Focal One® HIFU Sale To Foch Hospital, Paris
Growing Adoption of Focal One HIFU in France
EDAP To Report Third Quarter 2016 Financial Results On November 17, 2016
Conference Call and Webcast Scheduled for 8:30 a.m. ET
Ratings Changes Today
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMS, ASUR, EDAP Downgrades: ACSF, AG, ASYS, INFO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
EDAP To Report Second Quarter 2016 Financial Results On August 25, 2016
Conference Call and Webcast Scheduled for 8:30 a.m. ET
EDAP Announces First HIFU Treatments Performed In New England
Ablatherm Robotic HIFU Deployed by HIFU USA; Initial Treatments Performed in New York by Dr. Ron Israeli and in New England by Drs. Clifford Gluck and James Lin
First HIFU Patient Treated At Allied Urological Services In New York City With The Ablatherm® Robotic HIFU Device
Procedures Performed by Dr. Altan Ilkay
EDAP To Report First Quarter 2016 Results On May 18, 2016
Conference Call and Webcast Scheduled for 8:30 a.m. ET
